Running and Resistance Training Ease Menopause Symptoms, Experts Confirm

Menopause arrives with a familiar catalog of disruptions. Hot flashes that wake you at three in the morning. Nights soaked through with sweat. A dryness that makes intimacy uncomfortable. Mood swings that feel like they belong to someone else. Insomnia that leaves you hollow-eyed at the breakfast table. These are the symptoms that make women dread the transition, and they are real enough that they reshape daily life.

But there is something that can soften this passage, and it is not complicated: movement. Running. Strength training. The evidence, according to four specialists interviewed here, is now substantial enough that it deserves to be part of how women approach these years.

Dr. Nélio Veiga Junior, a gynecologist with advanced degrees in obstetrics and gynecology from the State University of Campinas, explains the mechanism. During menopause, estrogen plummets. This hormone's decline does real damage: it worsens cholesterol profiles, inflames the walls of blood vessels, stiffens arteries, and opens the door to cardiovascular disease—atherosclerosis, heart attack, stroke. Bone density erodes too, creating conditions for osteoporosis and fractures. But running, because it is a weight-bearing exercise, activates osteoblasts—the cells that build bone. It improves lipid profiles. It lowers blood pressure. It strengthens the heart muscle itself. The research backs this up. Studies in rodents showed that female mice subjected to eight weeks of treadmill running after surgical menopause experienced delayed bone loss and improved bone microstructure. Another study compared resistance training, treadmill running, sedentary behavior, and hormone replacement therapy in female rats. The cardiac function of rats that ran improved as much as those receiving estrogen replacement—a finding that suggests women who cannot tolerate hormone therapy might find comparable benefit in exercise.

A 2025 study published in PLOS examined how menopause symptoms affected female endurance athletes—runners, cyclists, swimmers, triathletes aged forty to sixty. Joint and muscle discomfort, weight gain, sleep problems, and physical and mental exhaustion emerged as the symptoms most damaging to training and performance. Women with more severe menopause symptoms perceived a greater negative impact on their athletic capacity. This matters because it means exercise is not a universal fix; individual assessment is necessary before beginning.

Dr. Igor Padovesi, a menopause specialist certified by the North American Menopause Society and author of "Menopause Without Fear," argues that any physical activity carries cardiovascular benefit, but the ideal approach combines aerobic work with resistance training. If forced to choose one, he would choose resistance training—weight training—over running alone. Dr. Ana Paula Fabrício, a gynecologist with advanced training in nutrition and age-related disease prevention, reinforces this. She sees in her practice that women who maintain consistency in running experience improved temperature regulation, better sleep, improved insulin resistance, and sustained weight management. But she always pairs running with strength training. "The greatest risk for menopausal women, alongside cardiovascular disease and cancer, is osteoporosis," she says. Her prescription: start with walking and weight training, gradually progress to running, but never abandon the weights. The combination—running and strength training, cycling and strength training, walking and strength training—produces what she calls fantastic results. "There is no health without physical activity," she emphasizes.

The question of hormone replacement therapy remains fraught, though the science has shifted. Dr. Padovesi argues that modern bioidentical hormone therapy carries no official contraindication, even for women with family cancer history, and that current evidence suggests it may actually reduce breast cancer incidence rather than increase it. Dr. Veiga takes a more measured view: hormone replacement is neither universally good nor bad. The risk depends on the type of hormone, duration of use, and the individual patient's profile. A 2026 review in the journal Maturitas found that combined estrogen-plus-progestin therapy carries the highest breast cancer risk, especially with prolonged use, while estrogen alone (for women without a uterus) showed reduced breast cancer incidence and mortality in long-term treatment. The type of progesterone matters too—micronized progesterone appears safer for breast tissue than synthetic alternatives. Modern prescription, both doctors agree, must be individualized, weighing symptoms, age, family history, cardiovascular risk, and the woman's own preference, always through shared decision-making.